Skip to main content
SpringerLink
Log in

Progressive Renal Failure with Lymphopenia

  • Chapter
  • First Online:
Pediatric Immunology

  • 49 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ancliff P, Blundell M, Cory G. Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia. Blood. 2006;108(7):2182–9.

    Article  CAS  Google Scholar 

  2. Massaad M, Ramesh N, Geha R. Wiskott-Aldrich syndrome: a comprehensive review. Ann N Y Acad Sci. 2013;1285(1):26–43.

    Article  CAS  Google Scholar 

  3. Sullivan K, Mullen C, Blaese R. A multi-institutional survey of the Wiskott-Aldrich syndrome. J Pediatr. 1994;125(6):876–85.

    Article  CAS  Google Scholar 

  4. Hoshino A, Shimizu M, Matsukura H, Sakaki-Nakatsubo H, Nomura K, Miyawaki TK. Allogeneic bone marrow transplantation appears to ameliorate IgA nephropathy in a patient with X-linked thrombocytopenia. J Clin Immunol. 2014;34(1):53–7.

    Article  CAS  Google Scholar 

  5. Imai K, Nonoyama S, Ochs HD. WASP (Wiskott-Aldrich syndrome protein) gene mutations and phenotype. Curr Opin Allergy Clin Immunol. 2003;3(6):427–36.

    Article  CAS  Google Scholar 

  6. Orange J, Roy-Ghanta S, Mace E. IL-2 induces a WAVE2-dependent pathway for actin reorganization that enables WASp-independent human NK cell function. J Clin Invest. 2011;121(4):1535–48.

    Article  CAS  Google Scholar 

  7. Ozcan E, Notarangelo L, Geha R. Primary immune deficiencies with aberrant IgE production. J Allergy Clin Immunol. 2008;122(6):1054–62.

    Article  CAS  Google Scholar 

  8. Buchbinder D, Nugent D, Fillipovich A. Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treatments. Appl Clin Genet. 2014;7:55–66.

    Article  CAS  Google Scholar 

  9. Albert M, Bittner T, Nonoyama S. X-linked thrombocytopenia (XLT) due to WAS mutations : clinical characteristics, long-term outcome, and treatment options. Blood. 2010;115(16):3231–8.

    Article  CAS  Google Scholar 

  10. Blundell M, Worth A, Bouma G, Thrasher A. The Wiskott-Aldrich syndrome: the actin cytoskeleton and immune cell function. Dis Markers. 2010;29(3–4):157–75.

    Article  CAS  Google Scholar 

  11. Thrasher A, Burns S. WASP: a key immunological multitasker. Nat Rev Immunol. 2010;10(3):182–92.

    Article  CAS  Google Scholar 

  12. Meyer-bahlburg A, Becker-herman S, Humblet-baron S. Wiskott-Aldrich syndrome protein deficiency in B cells results in impaired peripheral homeostasis. Blood. 2015;112(10):4158–70.

    Article  Google Scholar 

  13. Shin C, Kim M-O, Li D. Outcomes following hematopoietic cell transplantation for Wiskott–Aldrich syndrome. Bone Marrow Transplant. 2012;47(11):1428–35.

    Article  CAS  Google Scholar 

  14. Oshima K, Imai K, Albert M, Bittner T, Strauss G, Filipovich A, Morio T, Kapoor N, Dalal J, Schultz K, Casper J, Notarangelo L, Ochs H. Hematopoietic stem cell transplantation for X-linked thrombocytopenia with mutations in the WAS gene. J Clin Immunol. 2015;35(1):15–21.

    Article  Google Scholar 

  15. Abina SH-B, Gaspar H, Blondeau J, Caccavelli L, Charrier S, Buckland K. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome. JAMA. 2015;31315:1550–63.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Allergic Diseases, Department of Medicine, Mayo Clinic, Rochester, MN, USA

    Mollie Alpern

  2. Diagnostic Immunology Laboratory, Department of Pathology and Laboratory Medicine, Nationwide Children’s Hospital, Columbus, OH, USA

    Roshini S. Abraham

Authors
  1. Mollie Alpern
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roshini S. Abraham
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roshini S. Abraham .

Editor information

Editors and Affiliations

  1. Department of Immunology, School of Medicine, Research Center for Immunodeficiencies (RCID)Children’s Medical Center, Tehran University of Medical Sciences (TUMS), Tehran, Iran

    Nima Rezaei

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Alpern, M., Abraham, R.S. (2019). Progressive Renal Failure with Lymphopenia. In: Rezaei, N. (eds) Pediatric Immunology. Springer, Cham. https://doi.org/10.1007/978-3-030-21262-9_131

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-21262-9_131

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-21261-2

  • Online ISBN: 978-3-030-21262-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation